Centogene NV
NASDAQ:CNTG
Centogene NV
Operating Expenses
Centogene NV
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
Operating Expenses
-€55.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Operating Expenses
-€2.3B
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Operating Expenses
-€611.1m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-25%
|
|
Immatics NV
NASDAQ:IMTX
|
Operating Expenses
-€155.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Operating Expenses
-€160m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
Formycon AG
XETRA:FYB
|
Operating Expenses
-€23.3m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Operating Expenses?
Operating Expenses
-55.9m
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's Operating Expenses amounts to -55.9m EUR.
What is Centogene NV's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-21%
Over the last year, the Operating Expenses growth was 19%. The average annual Operating Expenses growth rates for Centogene NV have been -11% over the past three years , -21% over the past five years .